A citation-based method for searching scientific literature

Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish, Enchi Liu, Jose Luis Molinuevo, Thomas Montine, Creighton Phelps, Katherine P Rankin, Christopher C Rowe, Philip Scheltens, Eric Siemers, Heather M Snyder, Reisa Sperling. Alzheimers Dement 2018
Times Cited: 2207







List of co-cited articles
749 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
34


Neuropathological stageing of Alzheimer-related changes.
H Braak, E Braak. Acta Neuropathol 1991
16

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
14

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman,[...]. Lancet Neurol 2014
14

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
12

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
12


Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
Clifford R Jack, Heather J Wiste, Stephen D Weigand, Terry M Therneau, Val J Lowe, David S Knopman, Jeffrey L Gunter, Matthew L Senjem, David T Jones, Kejal Kantarci,[...]. Alzheimers Dement 2017
267
11

Classification of primary progressive aphasia and its variants.
M L Gorno-Tempini, A E Hillis, S Weintraub, A Kertesz, M Mendez, S F Cappa, J M Ogar, J D Rohrer, S Black, B F Boeve,[...]. Neurology 2011
10

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
10

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
Katya Rascovsky, John R Hodges, David Knopman, Mario F Mendez, Joel H Kramer, John Neuhaus, John C van Swieten, Harro Seelaar, Elise G P Dopper, Chiadi U Onyike,[...]. Brain 2011
9

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Howard H Feldman, Giovanni B Frisoni, Harald Hampel, William J Jagust, Keith A Johnson, David S Knopman,[...]. Neurology 2016
545
9

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.
Joanna M Wardlaw, Eric E Smith, Geert J Biessels, Charlotte Cordonnier, Franz Fazekas, Richard Frayne, Richard I Lindley, John T O'Brien, Frederik Barkhof, Oscar R Benavente,[...]. Lancet Neurol 2013
8

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
Elisabeth H Thijssen, Renaud La Joie, Amy Wolf, Amelia Strom, Ping Wang, Leonardo Iaccarino, Viktoriya Bourakova, Yann Cobigo, Hilary Heuer, Salvatore Spina,[...]. Nat Med 2020
144
7

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Bob Olsson, Ronald Lautner, Ulf Andreasson, Annika Öhrfelt, Erik Portelius, Maria Bjerke, Mikko Hölttä, Christoffer Rosén, Caroline Olsson, Gabrielle Strobel,[...]. Lancet Neurol 2016
767
7

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
7

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
7

Criteria for the diagnosis of corticobasal degeneration.
Melissa J Armstrong, Irene Litvan, Anthony E Lang, Thomas H Bak, Kailash P Bhatia, Barbara Borroni, Adam L Boxer, Dennis W Dickson, Murray Grossman, Mark Hallett,[...]. Neurology 2013
755
7

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.
Frank Jessen, Rebecca E Amariglio, Martin van Boxtel, Monique Breteler, Mathieu Ceccaldi, Gaël Chételat, Bruno Dubois, Carole Dufouil, Kathryn A Ellis, Wiesje M van der Flier,[...]. Alzheimers Dement 2014
971
7

Vascular dysfunction-The disregarded partner of Alzheimer's disease.
Melanie D Sweeney, Axel Montagne, Abhay P Sagare, Daniel A Nation, Lon S Schneider, Helena C Chui, Michael G Harrington, Judy Pa, Meng Law, Danny J J Wang,[...]. Alzheimers Dement 2019
195
6

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G Beach, Geidy E Serrano, Xiyun Chai, Nicholas K Proctor, Udo Eichenlaub, Henrik Zetterberg,[...]. Nat Med 2020
155
6

Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Marta Marquié, Marc D Normandin, Avery C Meltzer, Michael Siao Tick Chong, Nicolas V Andrea, Alejandro Antón-Fernández, William E Klunk, Chester A Mathis, Milos D Ikonomovic, Manik Debnath,[...]. Ann Neurol 2017
118
6

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.
Ian G McKeith, Bradley F Boeve, Dennis W Dickson, Glenda Halliday, John-Paul Taylor, Daniel Weintraub, Dag Aarsland, James Galvin, Johannes Attems, Clive G Ballard,[...]. Neurology 2017
6

Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
Rachel F Buckley, Elizabeth C Mormino, Jennifer S Rabin, Timothy J Hohman, Susan Landau, Bernard J Hanseeuw, Heidi I L Jacobs, Kathryn V Papp, Rebecca E Amariglio, Michael J Properzi,[...]. JAMA Neurol 2019
79
7

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Christopher C Rowe, Kathryn A Ellis, Miroslava Rimajova, Pierrick Bourgeat, Kerryn E Pike, Gareth Jones, Jurgen Fripp, Henri Tochon-Danguy, Laurence Morandeau, Graeme O'Keefe,[...]. Neurobiol Aging 2010
692
6

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Marta Marquié, Marc D Normandin, Charles R Vanderburg, Isabel M Costantino, Elizabeth A Bien, Lisa G Rycyna, William E Klunk, Chester A Mathis, Milos D Ikonomovic, Manik L Debnath,[...]. Ann Neurol 2015
389
6

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Rik Ossenkoppele, Daniel R Schonhaut, Michael Schöll, Samuel N Lockhart, Nagehan Ayakta, Suzanne L Baker, James P O'Neil, Mustafa Janabi, Andreas Lazaris, Averill Cantwell,[...]. Brain 2016
473
6

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
Rik Ossenkoppele, Gil D Rabinovici, Ruben Smith, Hanna Cho, Michael Schöll, Olof Strandberg, Sebastian Palmqvist, Niklas Mattsson, Shorena Janelidze, Alexander Santillo,[...]. JAMA 2018
127
6

APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
Axel Montagne, Daniel A Nation, Abhay P Sagare, Giuseppe Barisano, Melanie D Sweeney, Ararat Chakhoyan, Maricarmen Pachicano, Elizabeth Joe, Amy R Nelson, Lina M D'Orazio,[...]. Nature 2020
188
6

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Niklas Mattsson, Nicholas C Cullen, Ulf Andreasson, Henrik Zetterberg, Kaj Blennow. JAMA Neurol 2019
154
5

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
268
5

High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Akinori Nakamura, Naoki Kaneko, Victor L Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe,[...]. Nature 2018
508
5


Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen, José C Alvarez-Cermeño, Ulf Andreasson, Markus Axelsson, David C Bäckström, Ales Bartos,[...]. JAMA Neurol 2019
162
5

Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
Michelle M Mielke, Clinton E Hagen, Jing Xu, Xiyun Chai, Prashanthi Vemuri, Val J Lowe, David C Airey, David S Knopman, Rosebud O Roberts, Mary M Machulda,[...]. Alzheimers Dement 2018
155
5

Current state of Alzheimer's fluid biomarkers.
José Luis Molinuevo, Scott Ayton, Richard Batrla, Martin M Bednar, Tobias Bittner, Jeffrey Cummings, Anne M Fagan, Harald Hampel, Michelle M Mielke, Alvydas Mikulskis,[...]. Acta Neuropathol 2018
182
5

The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
5

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
Oskar Hansson, Sylvain Lehmann, Markus Otto, Henrik Zetterberg, Piotr Lewczuk. Alzheimers Res Ther 2019
86
5

Phases of A beta-deposition in the human brain and its relevance for the development of AD.
Dietmar R Thal, Udo Rüb, Mario Orantes, Heiko Braak. Neurology 2002
5

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, Anne M Fagan, Alison Goate, Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey,[...]. N Engl J Med 2012
5

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes.
Clifford R Jack, Heather J Wiste, Hugo Botha, Stephen D Weigand, Terry M Therneau, David S Knopman, Jonathan Graff-Radford, David T Jones, Tanis J Ferman, Bradley F Boeve,[...]. Brain 2019
51
9

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Niklas Mattsson, Philip S Insel, Michael Donohue, Susan Landau, William J Jagust, Leslie M Shaw, John Q Trojanowski, Henrik Zetterberg, Kaj Blennow, Michael W Weiner. Brain 2015
151
5

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
Gil D Rabinovici, Constantine Gatsonis, Charles Apgar, Kiran Chaudhary, Ilana Gareen, Lucy Hanna, James Hendrix, Bruce E Hillner, Cynthia Olson, Orit H Lesman-Segev,[...]. JAMA 2019
139
5


The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
5

Diagnostic criteria for vascular cognitive disorders: a VASCOG statement.
Perminder Sachdev, Raj Kalaria, John O'Brien, Ingmar Skoog, Suvarna Alladi, Sandra E Black, Deborah Blacker, Dan G Blazer, Christopher Chen, Helena Chui,[...]. Alzheimer Dis Assoc Disord 2014
282
5

Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.
Alexander Hammers, Richard Allom, Matthias J Koepp, Samantha L Free, Ralph Myers, Louis Lemieux, Tejal N Mitchell, David J Brooks, John S Duncan. Hum Brain Mapp 2003
672
5

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Niklas Mattsson, Ulf Andreasson, Henrik Zetterberg, Kaj Blennow. JAMA Neurol 2017
338
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.